辛伐他汀
焦磷酸香叶基香叶基
焦磷酸法尼酯
甲戊酸途径
半胱氨酸蛋白酶1
炎症
THP1细胞系
脂多糖
化学
生物
还原酶
药理学
内科学
生物化学
内分泌学
医学
ATP合酶
酶
细胞培养
炎症体
遗传学
作者
Loes M. Kuijk,Saskia H. L. Mandey,Ingrid M. M. Schellens,Hans R. Waterham,Ger T. Rijkers,Paul J. Coffer,Joost Frenkel
标识
DOI:10.1016/j.molimm.2007.12.008
摘要
Mevalonate kinase deficiency (MKD) is a hereditary syndrome characterized by recurring episodes of fever and inflammation. Peripheral blood mononuclear cells from MKD patients secrete high levels of interleukin (IL)-1beta when stimulated with lipopolysaccharide (LPS), which is thought to be a primary cause of the inflammation. However, the link between a deficient mevalonate kinase and excessive IL-1beta release remains unclear. To investigate this we made use of a model in which monocytic cells (THP-1) were treated with simvastatin. Statins are compounds that inhibit 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase and thereby artificially impair the isoprenoid biosynthesis pathway, mimicking mevalonate kinase deficiency. Our study revealed that LPS-stimulated THP-1 cells treated with simvastatin had an increased caspase-1 mediated processing of proIL-1beta. This increased processing was caused by enhanced autoprocessing of caspase-1, rather than enhanced transcription or translation of caspase-1 or proIL-1beta. Simvastatin-induced activation of caspase-1 was caused by an impairment of non-sterol isoprenoid biosynthesis, as the isoprenyl intermediate GGPP could block activation of caspase-1 and mIL-1beta release. In addition, inhibition of both farnesyl pyrophosphate synthase and geranylgeranyltransferase I also induce mIL-1beta release. Taken together, these results demonstrate that simvastatin augments LPS-induced IL-1beta release post-translationally, by inducing caspase-1 activity. These findings suggest that MKD patients may have overactive caspase-1, causing enhanced IL-1beta processing and subsequent inflammation in response to bacterial components.
科研通智能强力驱动
Strongly Powered by AbleSci AI